Cancer.Net’s Associate Editors discuss the most exciting research presented at the 2017 ASCO Annual Meeting.
The 2017 Clinical Cancer Advances report of the American Society of Clinical Oncology has announced that the Advance of the Year is Immunotherapy 2.0. Why 2.0? Because the role of immunotherapy in cancer care is expanding, and oncologists are learning how to use it more effectively.
Advocate Marcia Donziger describes how a cancer diagnosis changed everything and led her to a career in patient advocacy.
September is Gynecologic Cancer Awareness Month. Learn about new research on ovarian, fallopian tube, and peritoneal cancer in this expert podcast.
Women who survive gynecologic cancer have unique needs. Understanding and addressing these needs will help them celebrate and enjoy their lives after treatment ends.
In this podcast, Dr. Wright and Dr. Edelson discuss the new joint clinical practice guideline on the use of neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer from the Society of Gynecologic Oncology (SGO) and the American Society of Clinical Oncology (ASCO).
Oncology professionals from around the world are in Chicago for the ASCO Annual Meeting. There, they will discuss the latest advances and newest thoughts in cancer research. In today’s studies, researchers reveal how they look for new ways to use existing treatments in order to improve cancer care.
When Vinita Mathew was diagnosed with ovarian cancer, she had to figure out what to tell her sons. They were 5 and 18 months old at the time. In this guest post, she discusses ways to help a child understand cancer based on what she learned from her own experiences, as well as from other survivors and health care professionals.
Learn more about four studies that show the potential of new targeted therapies for advanced ovarian, lung, and thyroid cancers and chronic lymphocytic leukemia.